October is Breast Cancer Awareness Month – BriaCell is Advancing the Fight with its Immunotherapy

NEXT STORY
California Pediatricians Support State-Required COVID-19 Vaccination for Eligible Children and Safe In-Person Learning
PREV STORY
Scopus BioPharma to Present at the LD Micro Main Event
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cellceutix Provides Corporate Update; Significant Milestones Ahead as Multiple Mid-Phase Clinical Trials Set to Conclude

BEVERLY, Mass., May 10, 2017 (GLOBE NEWSWIRE) -- Cellceutix Corporation, (OTCQB:CTIX) (“the Company”), a ...

author_avatar
NASDAQ Market News

ANTIBIOTICS AWARENESS WEEK

CLINICAL STUDY CONFIRMS ECHINACEA CAN HELP DECREASE ANTIBIOTIC USE IN CHILDREN DURING COLD AND ...

author_avatar
NASDAQ Market News

Aeglea BioTherapeutics Doses First Patient in Phase 1 Trial of AEB1102 for the Treatment of Hematological Malignancies

AUSTIN, Texas, Aug. 29, 2016 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a biotechnology ...

author_avatar
NASDAQ Market News